These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3266542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ, Presl J, Broulík P, Pacovský V.
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G, Gamba P, Piana P, Pecchio F, Tizzani A.
    Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
    Gasser AB, Jeannet C, Depierre D, Courvoisier B.
    Schweiz Med Wochenschr; 1981 Feb 21; 111(8):246-51. PubMed ID: 7233140
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
    Shih WJ, Wierzbinski B, Collins J, Magoun S, Chen IW, Ryo UY.
    J Nucl Med; 1990 Sep 21; 31(9):1486-9. PubMed ID: 1697617
    [Abstract] [Full Text] [Related]

  • 11. Comparison between CEA, TPA, CA 15/3 and hydroxyproline, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer.
    Francini G, Montagnani M, Petrioli R, Paffetti P, Marsili S, Leone V.
    Int J Biol Markers; 1990 Sep 21; 5(2):65-72. PubMed ID: 2283479
    [Abstract] [Full Text] [Related]

  • 12. [Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
    Nemoto S, Rinsho K.
    Nihon Hinyokika Gakkai Zasshi; 1984 Jan 21; 75(1):53-8. PubMed ID: 6539837
    [No Abstract] [Full Text] [Related]

  • 13. Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.
    Hopkins SC, Nissenkorn I, Palmieri GM, Ikard M, Moinuddin M, Soloway MS.
    J Urol; 1983 Feb 21; 129(2):319-23. PubMed ID: 6834497
    [Abstract] [Full Text] [Related]

  • 14. Bone imaging and serum phosphatases in prostatic carcinoma.
    Bishop MC, Hardy JG, Taylor MC, Wastie ML, Lemberger RJ.
    Br J Urol; 1985 Jun 21; 57(3):317-24. PubMed ID: 4005501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K, Alfthan O, Ikonen T, Ruutu M, Rannikko S.
    Scand J Urol Nephrol; 1984 Jun 21; 18(3):181-5. PubMed ID: 6494827
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW, Siddall JK, Cooper EH.
    Eur Urol; 1988 Jun 21; 14(1):1-5. PubMed ID: 2449352
    [Abstract] [Full Text] [Related]

  • 19. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
    Rinsho K, Aoyagi K.
    Tohoku J Exp Med; 1982 Aug 21; 137(4):461-2. PubMed ID: 7123546
    [Abstract] [Full Text] [Related]

  • 20. [Blood levels of osteocalcin in hemodialysis patients. Significance and relations with uremic osteodystrophy].
    Bongiorno P, Biamino E, Caligaris F, Imarisio P, Montalcini G, Gentile G, Elia M, Arnaud A.
    Minerva Urol Nefrol; 1988 Aug 21; 40(4):323-6. PubMed ID: 3266950
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.